| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 生产不饱和脂肪酸含量提高之乳的方法 | CN201180055520.7 | 2011-10-18 | CN103237442A | 2013-08-07 | 耶罗恩·玛戈特·莱昂·赫克; 特奥·维克托尔·塞尔; 玛利亚·海伦娜·彼得罗内拉·威廉明娜·维斯科尔 |
| 本发明涉及不饱和脂肪酸含量提高并且反式脂肪酸含量降低的乳组合物。此外，本发明涉及通过用富脂饲料(fat-rich feed)喂养具有基因GDAT1之AA基因型的乳牛来得到这种乳的方法。另外，本发明涉及选择用于以富脂饲料添加剂(supplement)喂养之乳牛的方法以及测试富脂饲料添加剂的方法。在另一方面，本发明涉及减少在乳牛产乳期间甲烷排放和减少氨排放的方法。在另一方面，本发明涉及乳组合物在制备基于乳之产品中的用途以及基于其的产品。 | ||||||
| 2 | 和疏水性而展示出改善的乳液。包含亲脂性活性成分的营养组合物 | CN201580029571.0 | 2015-06-03 | CN106455662A | 2017-02-22 | P·琼斯; M·文玛; S·蒂米歇尔; G·凯慈 |
| 公开的实施方案提供了用于改善消费者新陈代谢健康的方法和组合物。牛β-酪蛋白，来自牛的乳的主要组分具有许多基因变体。某些基因变体，特别是A1，与1型糖尿病相关联。公开的方法和组合物包含降低量的与糖尿病相关联的β-酪蛋白基因变体。在一些实施方案中，所述组合物由于其中使用的β-酪蛋白基因变体的溶解度 | ||||||
| 3 | Milk production methods | JP2007534973 | 2005-10-06 | JP2008515814A | 2008-05-15 | ピーター マイケル ゲールリングス; クァン グァン テイ; ウイリアム ジョン ペンヘイル |
| a) i) 乳汁の半減期を低下させる原因となる少なくとも1つの微生物の生存のために必要な分子；ii) 乳汁の半減期を低下させる原因となる少なくとも1つの微生物の増殖のために必要な分子；iii) 他の微生物が乳汁の半減期を低下させるのを補助する少なくとも1つの微生物の生存に必要な分子；iv) 他の微生物が乳汁の半減期を低下させるのを補助する少なくとも1つの微生物の増殖に必要な分子；のうちの少なくとも1つに対して作製された抗体を乳汁に接触させる段階、を含む乳汁の半減期を改善する方法。 | ||||||
| 4 | METHOD FOR PRODUCTION OF MILK WITH A HIGH CONTENT OF NATIVE VITAMIN D | US15548495 | 2016-02-01 | US20180000043A1 | 2018-01-04 | Tony Gnann |
| The invention relates to a method for the production of milk with a high content of native vitamin D3, comprising the irradiation of one or more lactating animals in a roofed enclosure, having at least one luminaire with a lamp emitting UV-A and UV-B radiation, and the milking of animals. The method allows producing milk having a high content of native vitamin D. The method also leads to an improved milk yield per animal. | ||||||
| 5 | METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION | US12736143 | 2009-03-13 | US20110209228A1 | 2011-08-25 | Benjamin Cocks; German Spangenberg; Jianghui Wang |
| The present invention provides peptides and analogs and derivatives thereof having antimicrobial activity at least against Streptococcus uberis for the treatment of a range of infectious disease mastitis, otitis externa, clostridial intestinal disease and respiratory disease. | ||||||
| 6 | Milk production method | US11665374 | 2005-10-06 | US20090280210A1 | 2009-11-12 | Kwang Guan Tay; William John Penhale; Peter Michael Geerlings |
| A method for improving the half-life of milk comprising the step of: a) contacting milk with an antibody raised against at least one of the following: i) a molecule required for survival by at least a micro-organism that is responsible for reducing the half-life of milk; ii) a molecule required for growth by at least a micro-organism that is responsible for reducing the half-life of milk; iii) a molecule required for survival by at least a micro-organism that aids other micro-organisms to reduce the half-life of milk; iv) a molecule required for growth by at least a micro-organism that aids other micro-organisms to reduce the half-life of milk. | ||||||
| 7 | Lysosomal proteins produced in the milk of transgenic animals | US09516332 | 2000-03-01 | US20030097665A1 | 2003-05-22 | Arnold J.J. Reuser; Ans T. Van der Ploeg; Frank R. Pieper; Martin Ph. Verbeet |
| The invention provides transgenic nonhuman mammals producing phosphorylated lysosomal proteins in their milk, and methods of generating the same. Phosphorylation occurs at the 6null position of a mannose side chain residue. Also provided are methods of purifying lysosomal proteins from milk, and incorporating the proteins into pharmaceutical compositions for use in enzyme replacement therapy. | ||||||
| 8 | Lysosomal proteins produced in the milk of transgenic animals | US700760 | 1996-07-29 | US6118045A | 2000-09-12 | Arnold J. J. Reuser; Ans T. Van der Ploeg; Frank R. Pieper; Martin Ph. Verbeet |
| The invention provides transgenic nonhuman mammals producing phosphorylated lysosomal proteins in their milk, and methods of generating the same. Phosphorylation occurs at the 6' position of a mannose side chain residue. Also provided are methods of purifying lysosomal proteins from milk, and incorporating the proteins into pharmaceutical compositions for use in enzyme replacement therapy. | ||||||
| 9 | 高含有量の天然ビタミンＤを含む乳の製造方法 | JP2017540748 | 2016-02-01 | JP2018506279A | 2018-03-08 | グナン トニー |
| 本発明は、UVA光とUVB光を発するランプを有する少なくとも1つの照明器具を含む屋根付きの囲いの中で1頭以上の泌乳動物に照射を行うことと前記動物の搾乳を行うことを含む、高含有量の天然ビタミンD3を含む乳の製造方法に関する。この方法により、天然ビタミンD含有量の多い乳を製造でき、さらには1頭あたりの搾乳量を改善できる。 | ||||||
| 10 | How antibody production | JP2007534972 | 2005-10-06 | JP2008515813A | 2008-05-15 | ウィリアム・ジョン・ペンヘイル; クワン・グァン・タイ; ピーター・マイケル・へーリングス |
| 【課題】乳汁中で抗体の持続的な放出を誘導する方法を提供する。
【解決手段】ａ）少なくとも一つの乳腺上リンパ節に隣接若しくは十分近接した位置、又は前記リンパ節内に、少なくとも一つの抗原放出装置を埋め込む工程を含み、前記抗原放出装置は、使用中に前記乳腺上リンパ節周辺の組織領域に抗原を放出し、乳腺へ抗体分泌を刺激することを特徴とする乳汁に抗体の持続的な放出を誘導する方法である。 【選択図】なし |
||||||
| 11 | Lysosomal proteins produced in the milk of transgenic animals | JP50811397 | 1996-07-31 | JP2000501602A | 2000-02-15 | ピーペル，フランク，アール．; デル プレグ，アンス，ティー ファン; フェルビート，マーティン，ピーエイチ．; リューザー，アーノルド，ジェイ．，ジェイ． |
| (57)【要約】 本発明は、ミルク中にホスホリル化されたリソソーム性蛋白質を生成するトランスジェニック非ヒト哺乳動物およびそれを生成する方法を提供する。 ホスホリル化は、マンノース側鎖残基の６′位で生じる。 ミルクからのリソソーム性蛋白質を精製し、蛋白質を、酵素置換療法で使用するための薬剤組成物に加える方法がまた提供される。 | ||||||
| 12 | METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION | EP09720751 | 2009-03-13 | EP2257569A4 | 2011-08-24 | COCKS BENJAMIN; SPANGENBERG GERMAN; WANG JIANGHUI |
| 13 | METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION | EP09720751.8 | 2009-03-13 | EP2257569A1 | 2010-12-08 | COCKS, Benjamin; SPANGENBERG, German; WANG, Jianghui |
| The present invention provides peptides and analogs and derivatives thereof having antimicrobial activity at least against Streptococcus uberis for the treatment of a range of infectious disease including mastitis, otitis externa, clostridial intestinal disease and respiratory disease. | ||||||
| 14 | FUNCTIONAL COMPOSITION OR FOOD CONTAINING WHEY PROTEIN, ANTIBODY DERIVED FROM MILK, OR ANTIBODY | EP05788363 | 2005-09-27 | EP1795204A4 | 2009-10-21 | YAJIMA MIZUO; IWATSUKI SATOSHI; SHIONOYA HIROSHI; TERADO KUNIAKI; AKAMATSU HIROHISA; SUZUKI SHUUKA; KATOH MASAMICHI |
| A functional composition or food containing whey protein, an antibody derived from milk, or an antibody; and a whey protein food characterized by comprising whey protein and any of a glucide, cocoa powder, powdery non-coagulable insoluble, powdered green tea, aloe powder, turmeric powder, pumpkin powder, red grape juice powder, tomato powder, cranberry powder, raspberry powder, blueberry powder, and or strawberry powder. | ||||||
| 15 | LYSOSOMAL PROTEINS PRODUCED IN THE MILK OF NONHUMAN TRANSGENIC ANIMALS | EP96928405.8 | 1996-07-31 | EP0845939B1 | 2003-05-21 | REUSER, Arnold, J., J.; VAN DER PLOEG, Ans, T.; PIEPER, Frank, R.; VERBEET, Martin, Ph. |
| The invention provides transgenic nonhuman mammals producing phosphorylated lysosomal proteins in their milk, and methods of generating the same. Phosphorylation occurs at the 6' position of a mannose side chain residue. Also provided are methods of purifying lysosomal proteins from milk, and incorporating the proteins into pharmaceutical compositions for use in enzyme replacement therapy. | ||||||
| 16 | NUTRITIONAL COMPOSITIONS COMPRISING A LIPOPHILIC ACTIVE INGREDIENT | US15315987 | 2015-06-03 | US20170086481A1 | 2017-03-30 | PAUL JOHNS; MUSTAFA VURMA; STEPHEN DEMICHELE; GARY KATZ |
| Disclosed embodiments provide methods and compositions for improving the metabolic health of consumers. Bovine beta-casein, a major component of milk from cattle, has many genetic variants. Certain genetic variants, A1 in particular, have been associated with type 1 diabetes. The disclosed methods and compositions include reduced amounts of genetic variants of beta-casein that have been associated with diabetes. In some embodiments, the compositions display improved emulsions due to the solubility and hydrophobicity of the genetic variants of beta-casein used therein. | ||||||
| 17 | Method of Treating Protozoal Gastrointestinal Disorders in Immunocompromised Patients | US15253733 | 2016-08-31 | US20170056497A1 | 2017-03-02 | Joseph Whelihan; Jada Eley |
| The invention relates to a method for treating protozoal gastrointestinal disorders in immunocompromised patients. It includes a method for the isolation of a factor from the milk of hyperimmunized animals in a substantially pure form, and to the use of said factor in combination with vitamins and minerals. | ||||||
| 18 | Immunized Camel Milk-Based Composition for the Treatment or Prevention of Gastrointestinal Infections | US13609350 | 2012-09-11 | US20140072649A1 | 2014-03-13 | Khaled Mahmood Al-Qaoud; Penelope Ahmad Shihab; Luay Fawzi Abu-Qatouseh; Christopher R. Lowe |
| The present invention relates to a novel composition with milk of immunized camelid, particularly, (Camelus dromedarius) as the main component (i.e. active ingredient) and a method for the treatment or prevention of gastrointestinal infections, particularly, infections caused by Escherichia coli (E. coli), Helicobacter Pylori (H. pylori), Campylobacter jejuni (C. jejuni), Salmonella enterica, Shigella dysenteriae, Clostridium perfringens, or Yersinia enterocolitica. Said composition is prepared in the form of pharmaceutical, nutraceutical, or health food preparations. The present invention also discloses a process of preparing said composition. | ||||||
| 19 | Antibody production method | US11784278 | 2007-04-05 | US07862799B2 | 2011-01-04 | Kwang G. Tay; William J. Penhale; Peter M. Geerlings |
| A method of inducing the sustained release of antibodies in milk comprising the step of: a) implanting at least one antigen releasing device adjacent to, within close proximity of or within at least one supramammary lymph node, wherein in use the antigen releasing device releases an antigen into the tissue area around the supramammary lymph node which stimulates antibody secretion into a mammary gland. | ||||||
| 20 | Milk production method | US11787226 | 2007-04-13 | US20080107769A1 | 2008-05-08 | Kwang Tay; William Penhale; Peter Geerlings |
| A method for improving the half-life of milk comprising the step of: a) contacting milk with an antibody raised against at least one of the following: i) a molecule required for survival by at least a micro-organism that is responsible for reducing the half-life of milk; ii) a molecule required for growth by at least a micro-organism that is responsible for reducing the half-life of milk; iii) a molecule required for survival by at least a micro-organism that aids other micro-organisms to reduce the half-life of milk; iv) a molecule required for growth by at least a micro-organism that aids other micro-organisms to reduce the half-life of milk. | ||||||
QQ群二维码
意见反馈
意见反馈